182 related articles for article (PubMed ID: 9392933)
1. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
2. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
Muraoka A; Asami M; Ueno H; Yoneda R; Ogura M; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
[TBL] [Abstract][Full Text] [Related]
3. Prolymphocytic leukaemia.
Catovsky D
Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
[TBL] [Abstract][Full Text] [Related]
4. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
5. A brief intensive chemotherapy in T-prolymphocytic leukemia.
Billio A; Pescosta N; Rosanelli C; Fabris P; Coser P
Haematologica; 2000 Apr; 85(4):438-9. PubMed ID: 10756378
[No Abstract] [Full Text] [Related]
6. Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia.
Crisostomo RH; Fernandez JA; Caceres W
Leuk Res; 2007 May; 31(5):699-701. PubMed ID: 16997373
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia.
Montillo M; Tedeschi A; O'Brien S; Di Raimondo F; Lerner S; Ferrajoli A; Morra E; Keating MJ
Cancer; 2003 Jan; 97(1):114-20. PubMed ID: 12491512
[TBL] [Abstract][Full Text] [Related]
8. [Prolymphocytic leukemia: the therapeutic strategy].
Fava S; De Paoli A; Grimi E; Luoni M; Tocci A; Tosi A; Cassi E
Recenti Prog Med; 1994 Oct; 85(10):496-501. PubMed ID: 7809465
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.
Murase K; Matsunaga T; Sato T; Kuribayashi K; Kogawa K; Kawano Y; Okamoto T; Takayama T; Watanabe H; Niitsu Y; Hirayama Y
Int J Clin Oncol; 2003 Dec; 8(6):391-4. PubMed ID: 14663643
[TBL] [Abstract][Full Text] [Related]
10. [Chronic lymphocytic and prolymphocytic leukemia].
Gerrits CJ; Michiels JJ
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):826-30. PubMed ID: 7731474
[No Abstract] [Full Text] [Related]
11. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
12. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course.
Shvidel L; Shtalrid M; Bassous L; Klepfish A; Vorst E; Berrebi A
Leuk Lymphoma; 1999 Mar; 33(1-2):169-79. PubMed ID: 10194135
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous manifestations of T-cell prolymphocytic leukemia].
De Belilovsky C; Guillaume JC; Gilles E; Bosq J; Hayat M; Desvignes V; Avril MF
Ann Dermatol Venereol; 1989; 116(11):889-91. PubMed ID: 2619197
[No Abstract] [Full Text] [Related]
14. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
15. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Adiga GU; Abebe L; Wiernik PH
Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
[TBL] [Abstract][Full Text] [Related]
16. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
18. ProMACE day 1/MOPP day 8 chemotherapy for prolymphocytic leukemia: a case report of prolonged survival.
Yuen BH; Godwin JE
Am J Hematol; 1994 Jul; 46(3):230-3. PubMed ID: 8192154
[TBL] [Abstract][Full Text] [Related]
19. B-Prolymphocytic leukemia: a case study.
Roberts JC; Roberts GH
Clin Lab Sci; 2001; 14(4):233-7. PubMed ID: 11760820
[TBL] [Abstract][Full Text] [Related]
20. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
